Theo Melas-Kyriazi is an Operating Executive with SFW Capital Partners and a member of its Investment Committee. He worked for almost 20 years for Thermo Electron Corporation, now Thermo Fisher Scientific (NYSE: TMO), a globally leading provider of analytical instrumentation and related software, most recently serving as CFO. During his career at Thermo, he also served as Treasurer, VP of Corporate Strategy, and CEO of Thermo Spectra Corporation, a publicly-traded subsidiary of Thermo. Mr. Melas-Kyriazi currently serves as a CFO of Levitronix Technologies LLC and is a Director of Valeant Pharmaceuticals International (NYSE: VRX). He has a B.A. and an MBA from Harvard.. |
 |
 |